The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4. (Q38919859)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4. |
scientific article |
Statements
1 reference
The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4. (English)
1 reference
Li Liu
1 reference
Patrick A Mayes
1 reference
Stephen Eastman
1 reference
Hong Shi
1 reference
Sapna Yadavilli
1 reference
Tianqian Zhang
1 reference
Jingsong Yang
1 reference
Laura Seestaller-Wehr
1 reference
Shu-Yun Zhang
1 reference
Chris Hopson
1 reference
Lyuben Tsvetkov
1 reference
Junping Jing
1 reference
Shu Zhang
1 reference
James Smothers
1 reference
Axel Hoos
1 reference
14 January 2015
1 reference
1 reference
Identifiers
1 reference